Literature DB >> 32698094

In vitro hemocompatibility testing of medical devices.

Martina Nalezinková1.   

Abstract

Hemocompatibility testing is essential for the safe use of medical devices that come into contact with blood. There are various evaluation methodologies. In vivo, ex vivo and in vitro systems can be used and different categories can be evaluated in different ways. This review deals with in vitro hemocompatibility testing mainly on the basis of ISO standard 10993-4 recommendations and possibly new research results. This is a summary of all tested categories, i.e. coagulation, hemolysis, hematology and activation of leukocytes and platelets and the complement system. The main principle of evaluation and the possibilities of testing using various methodologies are always described. In the next part, variants of the method of blood incubation with the tested medical device from the static system to the circulation are described. Circulation can be provided, for example, by means of the Chandler Loop or parallel-plate chambers.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Coagulation; Hemocompatibility; Human blood; Leukocyte; Platelet

Mesh:

Year:  2020        PMID: 32698094     DOI: 10.1016/j.thromres.2020.07.027

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

1.  Comparison of the Hemocompatibility of an Axial and a Centrifugal Left Ventricular Assist Device in an In Vitro Test Circuit.

Authors:  Patrick Borchers; Patrick Winnersbach; Sandra Kraemer; Christian Beckers; Eva Miriam Buhl; Steffen Leonhardt; Rolf Rossaint; Marian Walter; Thomas Breuer; Christian Bleilevens
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

2.  Selected Physicochemical Properties of Diamond Like Carbon (DLC) Coating on Ti-13Nb-13Zr Alloy Used for Blood Contacting Implants.

Authors:  Magdalena Antonowicz; Roksana Kurpanik; Witold Walke; Marcin Basiaga; Jozef Sondor; Zbigniew Paszenda
Journal:  Materials (Basel)       Date:  2020-11-11       Impact factor: 3.623

3.  Hemocompatibility Evaluation of Thai Bombyx mori Silk Fibroin and Its Improvement with Low Molecular Weight Heparin Immobilization.

Authors:  Tanrada Fungmongkonsatean; Jirapas Jongjitwimol; Pussadee Paensuwan; Teonchit Nuamchit; Duangduan Siriwittayawan; Sorada Kanokpanont; Siriporn Damrongsakkul; Piyanuch Thitiwuthikiat
Journal:  Polymers (Basel)       Date:  2022-07-20       Impact factor: 4.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.